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Abstract
Objectives:  To  compare  mortality  and  morbidity  in  very  low  birth  weight  infants  (VLBWI)  born
to women  with  and  without  diabetes  mellitus  (DM).
Methods:  This  was  a  cohort  study  with  retrospective  data  collection  (2001--2010,  n  =  11.991)
from the  NEOCOSUR  network.  Adjusted  odds  ratios  and  95%  conﬁdence  intervals  were  calculated
for the  outcome  of  neonatal  mortality  and  morbidity  as  a  function  of  maternal  DM.  Women  with
no DM  served  as  the  reference  group.
Results:  The  rate  of  maternal  DM  was  2.8%  (95%  CI:  2.5-3.1),  but  a  signiﬁcant  (p  =  0.019)
increase was  observed  between  2001-2005  (2.4%,  2.1-2.8)  and  2006-2010  (3.2%,  2.8-3.6).  Moth-
ers with  DM  were  more  likely  to  have  received  a  complete  course  of  prenatal  steroids  than  those
without DM.  Infants  of  diabetic  mothers  had  a  slightly  higher  gestational  age  and  birth  weight
than infants  of  born  to  non-DM  mothers.  Distribution  of  mean  birth  weight  Z-scores,  small  for
gestational  age  status,  and  Apgar  scores  were  similar.  There  were  no  signiﬁcant  differences
between the  two  groups  regarding  respiratory  distress  syndrome,  bronchopulmonary  dyspla-
sia, intraventricular  hemorrhage,  periventricular  leukomalacia,  and  patent  ductus  arteriosus.
Delivery room  mortality,  total  mortality,  need  for  mechanical  ventilation,  and  early-onset  sep-
sis rates  were  signiﬁcantly  lower  in  the  diabetic  group,  whereas  necrotizing  enterocolitis  (NEC)
was signiﬁcantly  higher  in  infants  born  to  DM  mothers.  In  the  logistic  regression  analysis,  NEC
grades 2-3  was  the  only  condition  independently  associated  with  DM  (adjusted  OR:  1.65  [95%
CI: 1.2  -2.27]).
Conclusions:  VLBWI  born  to  DM  mothers  do  not  appear  to  be  at  an  excess  risk  of  mortality  or
early morbidity,  except  for  NEC.
© 2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
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Impacto  da  diabetes  mellitus  maternal  sobre  a  mortalidade  e  morbidade  de  crianc¸as
com  muito  baixo  peso  ao  nascer:  um  estudo  em  diversos  centros  da  América  Latina
Resumo
Objetivos:  Comparar  mortalidade  e  morbidade  em  crianc¸as  de  muito  baixo  peso  (MBP)  ﬁlhas
de mães  com  e  sem  diabetes  mellitus  (DM).
Métodos:  Estudo  de  coorte  com  coleta  retrospectiva  de  dados  (2001  -  2010,  n  =  11.991)  da  rede
NEOCOSUR.  Odds  ratios  ajustados  foram  calculados  para  mortalidade  e  morbilidade  neonatal
em func¸ão  da  DM  materna.  Mulheres  sem  DM  serviram  como  grupo  de  referência.
Resultados:  A  taxa  de  DM  materna  foi  2,8%  (IC  95%  2,5-3,1),  mas  um  aumento  signiﬁcativo
(p =  0,019)  entre  2001-2005  (2,4%)  e  2006-2010  (3,2%)  foi  observado.  As  mães  com  DM  eram
mais propensas  a  terem  recebido  um  curso  completo  de  esteróides  pré-natais  que  as  sem  DM.
Os bebês  de  mães  diabéticas  tinham  uma  idade  gestacional  e  peso  ao  nascer  um  pouco  maior  do
que crianc¸as  ﬁlhas  de  não  DM.  Distribuic¸ão  dos  z  escores  de  peso  ao  nascer,  pequeno  para  idade
gestacional  e  escores  de  Apgar  foram  semelhantes.  Não  houve  diferenc¸as  signiﬁcativas  entre
os dois  grupos  em  termos  de  síndrome  do  desconforto  respiratório,  displasia  broncopulmonar,
hemorragia  intraventricular,  leucomalácia  periventricular  e  persistência  do  ductus  arteriosus.
Mortalidade  na  sala  de  parto,  mortalidade  total,  necessidade  de  ventilac¸ão  mecânica  e  as  taxas
de sepse  neonatal  precoce  foram  signiﬁcativamente  menores  no  grupo  diabético,  enquanto
enterocolite  necrosante  (NEC)  foi  signiﬁcativamente  maior  em  recém-nascidos  de  mães  diabéti-
cas. Em  análises  de  regressão  logística  NEC  foi  a  única  condic¸ão  independentemente  associada
com DM  (OR  ajustado  1,65  [IC  95%  1,21  -2,27]).
Conclusões:  Crianc¸as  de  MBP  de  mães  com  DM  não  têm  aumento  do  risco  de  mortalidade  ou
morbidade precoce,  exceto  NEC.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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Diabetes  mellitus  (DM)  is  the  most  common  medical  condi-
tion  causing  complications  during  pregnancy.  It  is  estimated
that  0.2%  to  0.3%  of  all  pregnancies  are  complicated  by
pregestational  DM,  and  another  1%  to  5%  by  gestational  DM.1
Numerous  studies  indicate  that  the  rates  of  perinatal
complications  among  diabetic  women  are  still  substantially
higher  than  those  of  the  general  population.2
Although  there  has  been  considerable  progress  in  the  care
of  diabetic  pregnant  women,  the  risk  of  premature  deliv-
ery  remains  high.3 The  exact  incidence  of  prematurity  in
the  pregnant  diabetic  women  is  controversial.  A  large  series
reported  that  36%  of  infants  born  to  mothers  with  gesta-
tional  DM  or  those  with  pre-existing  insulin-dependent  DM
were  born  before  term,  compared  to  9.7%  in  the  general
population.4
Adequate  pre-conceptional  and  gestational  care  reduces
the  frequency  of  congenital  malformations  and  improves
pregnancy  outcomes.5
Despite  substantial  reductions  in  morbidity  and  mortal-
ity  rates  achieved  with  recent  advances  in  neonatal  care,
prematurity  remains  the  single  most  important  determinant
of  neonatal  morbidity  in  diabetic  pregnancies.6 Although  a
large  number  of  investigators  have  examined  the  inﬂuence
of  various  perinatal  risk  factors  on  the  outcome  of  very  low
birth  weight  infants  (VLBWI),  studies  that  speciﬁcally  has
focused  on  the  outcome  of  VLBWI  born  to  diabetic  mothers
are  scarce.7--9 Furthermore,  most  of  these  data  were  from
centers  with  a  special  interest  in  diabetes  and  pregnancy
2
e
h
hnd  no  difference  was  observed  between  pre-gestational
nd  gestational  DM.
The  present  study  aimed  to  compare  mortality  rates  and
arly  and  late  morbidity  rates  in  VLBWI  born  to  women  with
nd  without  DM  in  a  regional  birth  cohort  over  a  ten-year
eriod.
ethods
ata  collection
he  NEOCOSUR  South  American  Network  (http://www.
eocosur.org/neocosur/)  is  a  voluntary  nonproﬁts  asso-
iation  of  neonatal  intensive  care  units  (NICUs)  from
ix  South  American  countries  (Argentina,  Brazil,  Chile,
araguay,  Peru,  and  Uruguay),  whose  primary  objective  is
o  improve  neonatal  health.  Brieﬂy,  this  network  provides
 continuously  updated  database  that  prospectively  gathers
nformation  from  all  live-born  VLBWI  (birth  weight  ranging
rom  500  g  to  1,500  g)  from  the  participating  centers.
A  structured  form  is  completed  for  each  infant  using  pre-
eﬁned  diagnostic  criteria  on  maternal  demographic  details,
regnancy  history  and  antenatal  care,  delivery,  infant’s  sta-
us  at  delivery,  diagnoses,  procedures  and  complications
uring  hospitalization,  and  outcome  at  discharge.  Since
001,  data  is  prospectively  and  routinely  collected  and
ntered  online  at  the  NEOCOSUR  Network  Center.  The  data
ave  been  extensively  validated,  and  the  analyses  of  subsets
ave  been  reported  in  many  articles  to  date.10,11
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This  was  a  cohort  study  with  retrospective  data  collec-
ion  gathered  at  the  NEOCOSUR  Network  between  2001  and
010.  To  screen  for  and  diagnose  DM,  the  World  Health  Orga-
ization  (WHO)  protocol  was  employed,  because  it  is  more
nclusive  and  simple,  with  an  75-g  oral  glucose  tolerance
est  recommended  at  24--28  weeks  for  all  women  with  risk
actors  for  gestational  DM.12 As  this  was  a  study  across  22
aternity  units,  this  criteria  was  not  universally  followed,
nd  some  individual  centers  used  local  criteria  to  screen  for
nd  diagnose  DM.
utcome  measures
he  gestational  age  (GA)  in  completed  weeks  was  deﬁned
s  the  best  estimate  of  GA  on  the  basis  of  last  menstrual
eriod  and  early  prenatal  ultrasound  examination.  Prematu-
ity  was  deﬁned  according  to  WHO13 and  was  classiﬁed  into
he  following  subgroups:  extremely  preterm  (<  28  weeks),
ery  preterm  (28-31  weeks),  and  late  or  moderately  preterm
32-36.6  weeks).
Because  the  entry  cutoff  in  the  database  is  determined
y  a  birth  weight  of  ≤  1,500  g,  and  since  small  for  GA
SGA)  infants  might  theoretically  be  overrepresented,  the
uthors  chose  to  include  only  those  infants  who  were  deliv-
red  before  36  completed  weeks  in  this  analysis,  which
esulted  in  the  exclusion  of  20  infants.  Twenty-two  infants
elow  22  weeks  of  gestation  were  also  excluded,  because
ost  of  them  did  not  survive.  Three  additional  infants  were
xcluded  due  to  unknown  GA,  and  110  for  unknown  DM  sta-
us  of  the  mother.  Thus,  10,867  deliveries  and  11,991  infants
ere  included  in  the  analysis.
The  gender-speciﬁc  birth  weight  Z-score  was  calculated
n  accordance  with  a  local  intrauterine  growth  chart.14
ccording  to  Gruenwald,15 SGA  and  large  for  GA  (LGA)  were
eﬁned  when  the  weight  for  GA  and  sex  were  less  or  more
han  two  Z  scores  apart  from  its  expected  median,  respec-
ively.  Results  for  SGA  (n  =  308)  and  LGA  (n  =  1,055)  are  only
resented  for  GA  22-32  weeks,  in  order  to  prevent  overrep-
esentation  of  both  conditions.
Respiratory  distress  syndrome  (RDS)  was  diagnosed
ccording  to  clinical  and  radiologic  criteria.  Necrotizing
nterocolitis  (NEC)  was  diagnosed  by  the  presence  of  clini-
al  and  radiologic  characteristics  according  to  the  criteria
f  Bell  et  al.16 Only  deﬁnite  NEC  (Bell  grades  2  and  3)
ases  were  included.  Intraventricular  hemorrhage  (IVH)  and
eriventricular  leukomalacia  (PVL)  were  diagnosed  using
ranial  ultrasonography,  and  IVH  was  graded  using  the  clas-
iﬁcation  of  Papile  et  al.17 Bronchopulmonary  dysplasia
BPD)  was  deﬁned  according  to  the  criteria  of  Bancalari  &
laure,  including  clinical  and  radiologic  features  together
ith  the  requirement  of  oxygen  supplementation  at  28  days
f  age  or  at  36  weeks  of  postmenstrual  age.18 Patent  duc-
us  arteriosus  (PDA)  was  diagnosed  according  to  clinical
nd  ultrasonographic  criteria.  Early-onset  sepsis  was  deﬁned
n  the  presence  of  positive  blood  culture  before  72  hours
f  life.  Delivery  room  resuscitation  was  deﬁned  as  one  or
ore  of  the  following:  oxygen  treatment,  Ambu  bag  ven-ilation,  intubation  for  ventilation,  cardiac  massage,  and
pinephrine  administration.  Combined  rate  of  mortality  or
ajor  complications  included  death  or  BPD,  IVH  3-4,  and
EC  2-3.
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The  NEOCOSUR  score  is  a  neonatal  mortality  risk  score
eveloped  for  VLBWI  based  on  variables  present  at  birth,
efore  NICU  admission,  and  it  is  an  important  tool  for  com-
arison  between  NICUs  in  developing  countries.10 Surfactant
reatment  for  preterm  infants  was  the  standard  of  care  in
ll  the  NEOCOSUR  NICUs  during  the  study  period.
tatistical  analysis
 sample  size  calculation  assuming  25%  in  hospital  mortality
ate  for  the  children  of  nondiabetic  mothers  showed  that
t  80%  power  and  5%  signiﬁcance  level,  this  study  could
etect  a risk  of  1.5  in  144  infants  of  diabetic  mothers  and
77  infants  born  to  non-DM  (NDM)  mothers.
Maternal  characteristics  and  neonatal  outcomes  between
M  and  NDM  groups  were  compared  using  the  chi-squared
est  for  categorical  variables  and  Student’s  t-test  or  Mann-
hitney’s  test  for  continuous  variables.  Bivariate  analysis
as  applied  to  examine  the  effect  of  maternal  diabetic
tatus  (DM  or  NDM)  on  mortality  and  several  morbidities
f  VLBW  infants.  Multivariable  logistic  regression  analysis
as  used  to  assess  the  independent  effect  of  DM  status  on
ortality  and  other  complications  of  prematurity.  A  ﬁxed
et  of  clinically  important  variables  was  introduced  into
he  models:  maternal  age,  multiple  pregnancy,  maternal
ypertensive  disorders,  prenatal  steroid  treatment,  mode
f  delivery,  need  for  delivery  room  resuscitation,  gender,
A,  and  birth  weight  Z-score.
The  results  of  the  logistic  models  are  presented  as
djusted  odds  ratios  with  the  95%  conﬁdence  intervals.  Stata
.2  software  (College  Station,  Texas,  USA)  was  used  for  all
tatistical  calculations.  A  signiﬁcance  level  of  5%  was  used
ut,  because  of  the  large  numbers,  many  of  the  differ-
nces  examined  were  extremely  statistically  signiﬁcant  so,
or  convenience,  any  p-value  <  0.001  has  been  truncated  to
his  value.
Furthermore,  because  it  is  likely  that,  in  the  present
opulation,  public  and  private  maternity  units  had  differ-
ng  outcomes  for  VLBWI  during  the  study  period,  the  authors
lso  investigated  rates  of  DM  and  compared  perinatal  out-
omes  between  both  groups  in  DM  mothers.  In  addition,  the
eriods  between  2001-2005  and  2006-2010  were  compared
o  explore  whether  there  were  any  impact  in  diagnoses  or
reatment  practices  on  perinatal  outcomes  of  diabetic  preg-
ancies  across  time.
The  research  was  conducted  in  accord  with  prevailing
thical  principles  and  was  approved  by  the  Institutional
eview  Board  of  the  Catholic  University.
esults
rom  January  of  2001  to  December  of  2010,  12,146  VLBWI
ere  registered  in  the  database,  accounting  for  >  93%  of  all
ive-born  VLBWI  of  NEOCOSUR  centers.
A  total  of  304  pregnancies  in  women  with  pre-existing
M  (type  1  autoimmune  disease,  insulin-resistant  type  2,
ut  controlled  by  medication  or  insulin)  or  gestational  DM
whether  requiring  insulin  or  not)  that  ended  during  the
en-year  study  period  were  identiﬁed.  The  remainder  (n=
0,563)  were  pregnancies  without  DM.
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Table  1  Comparison  of  maternal  demographic,  pregnancy  and  delivery  characteristics,  diabetic  versus  nondiabetic  mothers.
Characteristic  Diabetic  (n  =  304)  Non-diabetic  (n  =10,563)  pb
n  (%)a n  (%)a
Maternal  age  (y)c 32.6  (6.5)  27.4  (7.3)  0.008
< 16  2  (0.5)  243  (2.3)  <  0.001
16-19 10  (3.1)  1,510  (14.2)
20-35 184  (60.4)  7,108  (67.3)
> 35 108  (35.8) 1,702  (16.1)
Education (High  School) 179/219  (82) 6,109/7,162  (85.3) 0.143
Prenatal care 294/301  (97.9) 9,039/10,426  (86.7) <  0.001
Multiple pregnancy 43  (14.1) 1,081  (10.2) 0.027
Hypertensiond 140  (46.1)  2820  (26.7)  <  0.001
Non vaginal  delivery  253  (83.5)  7,267  (68.8)  <  0.001
Prenatal steroids  300  (98.8)  10,402  (98.4)
Complete 221  (73.7)  5,715  (54.9)  <  0.001
Partial 45  (14.8)  2,010  (19.3)
None 34  (11.4)  2,677  (25.7)
a The denominator, when speciﬁed, indicates that there were some missing values.
b Student’s t-test or chi-squared test between diabetic and nondiabetic mothers.
m
h
d
t
d
tc Mean (SD).
d Chronic hypertension plus pregnancy-induced hypertension.
The  rate  of  ‘DM  pregnancy’  was  2.8%  (95%  CI  2.5--3.1)
or  one  in  every  35  deliveries.  The  corresponding  ﬁgures  for
public  and  private  centers  were  2.8%  (238/8,238;  1:33)  and
2.5%  (66/2,629;  1:39;  p  =  0.305),  respectively.  The  secular
trend  showed  a  statistically  signiﬁcant  increase  in  DM  preg-
nancies  between  2001-2005  (2.4%,  95%  CI:  2.1-2.8)  and  2006
-2010  (3.2%,  95%  CI:  2.8-3.6)  periods  (p  =  0.019).Table  1  lists  the  demographic,  pregnancy,  and  deliv-
ery  characteristics  among  DM  compared  with  NDM  women.
Brieﬂy,  mothers  in  the  DM  group  were  older  and  were
m
p
d
Table  2  Comparison  of  infants  characteristics,  diabetic  versus  no
Characteristic  Diabetic  (n  =  347)a
Male  genderc 171/346  (49.4)  
Gestational age  (weeks)c 29.6  (2.6)  
Extremely pretermd 73  (21.2)  
Very pretermd 187  (53.8)  
Late pretermd 87  (25.0)  
Birth weight  (g)c 1138  (262)  
Birth weight  Z-scorec −1.29  (2.3)  
Birth weight  Z-scorec,e −0.64  (1.4)  
SGAd,e 11/300  (3.6)  
LGAd,e 38/300  (12.6)  
Apgar score  at  5  min  ≤  3d 16/345  (4.6)  
Delivery room  resuscitationd,f 154/342  (45.0)  
SGA, small for gestational age (less than two Z scores apart from its ex
scores apart from its expected median).
a The denominator, when speciﬁed, indicates that there were some m
b Student’s t-test or chi-squared test between diabetic and nondiabe
c Mean (SD).
d n (%).
e Gestational age 22-32 weeks.
f Deﬁned as one or more of the following: oxygen treatment, Ambu 
administration of epinephrine.ore  likely  to  have  attended  more  prenatal  care;  have
ad  multiple  pregnancies,  hypertensive  disorders,  cesarean
eliveries;  and  to  have  received  a  complete  course  of  prena-
al  steroids.  No  interaction  was  found  between  hypertensive
isorders  and  SGA  (p  for  interaction  =  0.701).
Table  2  present  infants  characteristics,  and  due  to  mul-
iple  births,  the  numbers  are  higher  than  those  of  the
others.  The  DM  group  had  a  slightly  higher  GA,  lower  pro-
ortion  of  extremely  preterm  infants,  and  lower  need  of
elivery  room  resuscitation,  but  higher  mean  birth  weight
ndiabetic  mothers.
Nondiabetic  (n  =11,644)a pb
5,930/11,618  (51.4)  0.552
28.9  (2.9)  <  0.001
3644  (31.3)  <  0.001
5595  (48.1)  0.031
2405  (20.6)  0.045
1085  (279)  <  0.001
−1.14  (2.1)  0.207
−0.55  (1.2)  0.241
297/10,265  (2.9)  0.432
1017/10,265  (9.9)  0.116
736/11,514  (6.4)  0.187
6410/11,550  (55.5)  <  0.001
pected median); LGA, large for gestational age (more than two  Z
issing values.
tic mothers.
bag ventilation, intubation for ventilation, cardiac massage, and
238  Grandi  C  et  al.
Table  3  Infant  mortality  and  morbidities,  diabetic  versus  nondiabetic  mothers.
Characteristic  Diabetic  (n  =  347)a Nondiabetic  (n  =  11,644)a pb
NEOCOSUR  Scorec 0.189  (0.246)  0.242  (0.265)  0.002
Delivery room  deathd 6/291  (2.0)  433/9,468  (4.5)  0.041
All deaths  in  hospitald 65/344  (18.9)  2,919/11,541  (25.3)  0.007
RDSd 242/341  (70.9)  8,244/11,270  (73.1)  0.370
Mechanical ventilationd 197/341  (57.7)  7,205/11,252  (64.0)  0.017
Mechanical ventilation  (days)e 1  (5) 2  (7) 0.008
CPAP (days)e 1  (3) 1  (4) 0.572
Surfactant dosese 1  (2) 1  (2) 0.454
BPD 28  daysd 80/336  (23.8)  2,688/10,996  (24.4)  0.789
BPD 36  weeksd 56/309  (18.1)  1,805/10,357  (17.4)  0.751
NEC grades  2-3d 52/340  (15.3)  1,238/11,256  (11.0)  0.013
IVH grades  3-4d 9/309  (2.9)  456/11,991  (3.8)  0.417
PVLd 13/329  (3.9)  552/10,781  (5.1)  0.341
PDAd 86/338  (25.4)  2875/11,179  (25.7)  0.909
Early-onset sepsisd 5/335  (1.5)  409/11,172  (3.6)  0.035
Combined major  complicationsd (death  or
BPD/IVH  3-4/NEC  2-3)
190/347  (54.7)  7208/11,644  (61.9)  0.006
RDS, respiratory distress syndrome; CPAP, continuous positive airway pressure; BPD, bronchopulmonary dysplasia; NEC, necrotizing
enterocolitis; IVH, intraventricular hemorrhage; PVL, periventricular leukomalacia; PDA, patent ductus arteriosus.
a The denominator, when speciﬁed, indicates that there were some missing values.
b Student’s t-test, Mann-Whitney, or chi-squared tests between diabetic and nondiabetic mothers.
c Mean (SD).
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Table  4  Crude  and  adjusted  odds  Ratios  and  95%  CI  for
mortality  and  morbidities  among  preterm  VLBW  infants  of
diabetic  mothers.
Variable Crude  OR
(95%  CI)
Adjusted  OR
(95%  CI)
Delivery  room
death
0.43  (0.19-0.99)  1.14  (0.44-2.92)
All deaths  in
hospital
0.68  (0.52-0.90)  1.19  (0.86-1.65)
RDS 0.89  (0.70-1.13)  1.18  (0.90-1.56)
Mechanical
ventilation
0.76 (0.61-0.95)  1.08  (0.82-1.41)
BPD 28  days  0.96  (0.74-1.24)  1.20  (0.91-1.58)
BPD 36  weeks  1.04  (0.78-1.40)  1.22  (0.89-1.67)
IVH grades  3-4  0.63  (0.48-0.83)  0.87  (0.65-1.17)
PVL 0.76  (0.43-1.33)  0.97  (0.55-1.72)
NEC grades  2-3  1.46  (1.08-1.97)  1.65  (1.21-2.27)
PDA 0.99  (0.77-1.28)  1.17  (0.89-1.54)
Early-onset
sepsis
0.39 (0.16-0.96)  0.45  (0.16-1.24)
Combined  major
complications
0.74  (0.59-0.91)  1.01  (0.71  -1.43)
VLBW, very low birth weight; OR, odds ratio; CI, conﬁdence
interval.
ad n (%).
e Median (interquartile range).
han  the  NDM  group.  The  mean  standardized  birth  weight
core  (Z-score)  was  nearly  identical  for  both  groups.
Table  3  compares  the  mortality  rates  and  major  neona-
al  complications  between  the  two  groups.  The  NEOCOSUR
core,  delivery  room  death,  in-hospital  mortality,  mechan-
cal  ventilation,  early-onset  sepsis,  and  combined  major
omplications  rates  were  signiﬁcantly  lower  in  the  diabetic
roup.  Noteworthy,  the  rate  of  NEC  was  the  only  morbidity
igniﬁcantly  higher  in  the  DM  group.
After  adjustment  in  the  logistic  regression  analyses,  NEC
rades  2-3  was  the  only  condition  independently  associated
ith  DM  group  (Table  4).
Public  centers  (n  =  9,090)  showed  an  increased  risk  of
EC  grades  2-3  compared  with  private  centers  (n  =  2,901)  for
LBWI  born  to  DM  mothers  (adjusted  OR:  1.67;  95%  CI:  1.22-
.28;  p  <  0.001);  the  remaining  perinatal  outcomes  were  not
igniﬁcantly  different  between  centers.  Also,  NEC  grades  2-
 was  the  only  disease  that  showed  an  increased  risk  in  the
006-2010  period  (n  =  6,684)  compared  with  the  2001-2005
eriod  (n  =  5,307)  for  VLBWI  born  to  DM  mothers  (p  =  0.001),
hereas  the  other  outcomes  did  not  differ  among  periods.
iscussion
o  the  best  of  the  authors’  knowledge,  this  is  the  ﬁrst  study
n  Latin  America  to  investigate  the  association  between
aternal  DM  and  perinatal  outcomes  in  VLBWI  in  the  past
ecade.  The  sample  size  was  large,  and  the  study  period
llowed  for  the  analysis  of  temporal  trends.
The  current  study  unexpectedly  demonstrated  that  the
isk  of  mortality  or  early  morbidity  was  not  increased  in  a
arge  number  of  small  preterm  infants  born  to  DM  mothers,
Adjusted for maternal age, multiple pregnancy, maternal
hypertensive disorders, prenatal steroid treatment, mode of
delivery, need for delivery room resuscitation, gender, gesta-
tional age, and birth weight Z-score.
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tVery  low  birth  weight  infants  of  diabetic  mothers  
all  born  with  a  birth  weight  of  <  1,500  g,  when  compared  with
infants  born  to  NDM  mothers  in  a  regional  birth  cohort  over
a  ten-year  period.  Moreover,  multivariable  analysis  did  not
identify  maternal  DM  as  a  risk  factor  for  mortality  or  early
morbidity,  except  NEC,  in  this  population  of  preterm  VLBWI.
In  recent  years,  the  care  of  obstetric  DM  patients  has
changed,  and  it  is  likely  that  this  could  have  resulted  in  the
trend  for  improvements  in  detection,  glycemic  control,  and
pregnancy  outcomes  among  obstetric  DM  patients.
In  a  recent  review  of  the  prevalence  of  gestational  DM  in
European  countries,  the  reported  ﬁgures  were  between  2.0%
and  6.0%  in  over  half  of  the  studies.2 In  a  previous  study  of
DM  in  VLBW  pregnancies,  the  prevalence  was  higher  (5.4%)
than  the  present  study’s  ﬁgure  of  2.8%.6 However,  estimating
the  prevalence  of  gestational  DM  is  made  difﬁcult  by  a  lack
of  a  universally  accepted  diagnostic  criteria.19
Poor  glycemic  control  is  associated  with  an  increased  risk
of  pre-eclampsia,20 and  may  explain  the  fact  that  the  rate
of  maternal  hypertensive  disorders  were  more  prevalent  in
the  DM  group.  Also,  it  was  reported  that  obesity,  in  addition
to  DM,  was  associated  with  a  greater  risk  of  preeclampsia
than  either  factor  alone,  thereby  implicating  other  poten-
tial  mechanisms  such  as  inﬂammation  in  the  development
of  preeclampsia  in  this  high-risk  group.21
Women  with  DM  were  more  likely  to  have  cesarean-
section  and  vaginal  operative  delivery  than  normoglycemic
women.  In  addition,  the  trend  for  increased  pre-pregnancy
BMI  observed  in  Latin  America,22 coupled  with  higher  mul-
tiple  births  and  hypertension,  might  have  partly  explained
the  avoidance  of  vaginal  delivery  as  the  best  choice  for  DM
patients  in  the  present  study.2
In  international  literature,  patients  suffering  from  gesta-
tional  or  pre-existing  DM  are  generally  exposed  to  a  higher
risk  of  preterm  delivery.23 A  possible  explanation  is  that  DM
patients  who  did  not  achieve  the  desired  level  of  glycemic
control  reﬂect  a  subgroup  of  patients  with  poorer  compli-
ance  and  higher  risk  of  preterm  VLBW  delivery.
Length  of  gestation  was  somewhat  greater,  whereas
a  lower  proportion  of  extremely  preterm  infants  were
observed  in  the  DM  group.  This  may  be  due  to  modern  man-
agement  and  adequate  glycemic  control  in  pregnancy  that
led  to  prolonged  gestation  and  lower  risk  of  VLBW  neonatal
mortality  and  morbidity  in  pregnancies  complicated  by  DM.
There  were  no  signiﬁcant  differences  in  anthropomet-
ric  characteristics  between  the  two  groups  at  birth  (except
birth  weight),  in  agreement  with  a  population-base  study  in
Israel.7
Apgar  scores  were  similar  in  both  groups  in  accordance
with  previous  studies,7--9 although  resuscitation  provided
was  signiﬁcantly  lower  in  the  DM  group.
The  signiﬁcantly  lower  NEOCOSUR  Score  observed  in  the
DM  group  is  in  accordance  with  total  mortality  during  hospi-
tal  stay  that  was  signiﬁcantly  increased  in  the  NDM  group.
The  prevalence  of  respiratory  morbidity  was  similar  in
the  two  study  populations,  while  severity,  illustrated  by  the
need  for  ventilatory  support  and  median  number  of  days  on
mechanical  ventilation,  were  statistically  lower  in  the  DM
group.  Clinical  studies  on  the  effects  of  maternal  diabetes
on  fetal  pulmonary  maturation  have  produced  conﬂicting
data,9,24 possibly  due  to  the  differences  in  diabetic  control,
prenatal  steroids,  sex  distribution,  GA,  mode  of  delivery,
birth  asphyxia,  deﬁnition  of  RDS,  and  the  severity  of  disease
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n  different  study  populations.  The  present  ﬁndings  further
upport  this  observation;  i.e.,  after  controlling  for  GA,  sex,
nd  mode  of  delivery,  there  was  no  increase  in  the  likelihood
f  RDS.
This  was  also  true  for  other  major  complications  of  pre-
aturity,  such  as  rates  of  BPD  at  28  days’  or  36  weeks’
ostmenstrual  age,  PDA,  IVH,  or  PVL.  Conversely,  early-
nset  sepsis  and  combined  major  complications  were  more
requent  in  the  NDM  group.
In  bivariate  analyses,  the  odds  ratio  of  delivery  room
eath,  all  deaths  in  hospital,  mechanical  ventilation,
VH  grades  3-4,  early-onset  sepsis  and  combined  major
omplications  were  signiﬁcantly  lower  in  the  VLBWI  of  DM
roup  than  in  the  control  group.  The  authors  speculate  that
hese  differences  may  have  been  in  part  a  result  of  a  com-
ination  of  factors  such  as  (1)  a  slightly  higher  GA  and  birth
eight  in  the  DM  group  and  (2)  a  signiﬁcantly  higher  rate
f  completed  courses  of  prenatal  steroids  in  the  DM  group,
hich  may  be  linked  to  better  prenatal  care.  In  the  present
tudy,  approximately  80%  of  infants  in  both  groups  were
xposed  to  prenatal  steroids.  Moreover,  a  Cochrane  analysis
evealed  that  prenatal  steroid  therapy  decreases  the  risks
f  BPD  and  IVH.25 A  third  factor  was  differences  in  mode  of
elivery:  there  was  a  higher  rate  of  cesarean  deliveries  in
he  group  with  DM.  Although  the  topic  is  highly  controver-
ial,  some  retrospective  studies  indicate  that  there  might
e  a  reduced  rate  of  complications  related  to  prematurity
hen  the  infant  is  delivered  by  cesarean  section.26 Other
nﬂuential  factors  include  differences  in  the  rate  of  mater-
al  hypertensive  disorders,  which  were,  as  expected,  more
revalent  in  the  group  with  DM;  it  appears  that  preeclampsia
ight  reduce  the  risk  for  developing  RDS.27
In  the  multivariable  analyses,  only  NEC  persisted  inde-
endently  associated  with  a  higher  risk  in  VLBWI  born  to
M  mothers.  Its  pathogenesis  is  multifactorial  and  involves
n  overreactive  response  of  the  immune  system  to  an
nsult  (i.e.  infectious  or  response  to  translocation  of  normal
nteric  bacteria).28 Because  cesarean  section-born  individ-
als  do  not  make  contact  at  birth  with  maternal  vaginal  and
ntestinal  bacteria,  this  could  lead  to  long-term  changes  in
he  gut  microbiota  that  could  contribute  to  NEC.  Further-
ore,  NEC  was  the  only  morbidity  more  frequently  observed
n  public  centers  and  showed  a  signiﬁcant  trend  in  the  study
eriod.  In  a  population  study  NEC  was  not  associated  with
M,  although  rates  halved  that  observed  in  the  present
tudy.7
This  was  a retrospective  cohort  study  including  22  dif-
erent  maternity  units  in  the  Latin-American  region,  and
onsequently  some  inconsistency  in  the  screening  methods
nd  diagnosis  of  DM  are  to  be  expected.  This  may  have  led
o  the  underreporting  of  DM  cases  in  some  units,  and  conse-
uently  the  inclusion  of  some  women  with  occult  diabetes
n  the  NDM  group.
Another  limitation  of  the  present  study  is  that  the  type
f  DM  and  the  degree  of  glycemic  control  was  not  prospec-
ively  recorded  in  the  database.  Although  pre  =  gestational
nd  gestational  DM  involve  distinct  metabolic  alterations,
he  infant  population  of  this  study  represents  the  group  of
LBWI  born  after  in  utero  exposure  to  diabetic  milieu  in
he  mother.  In  addition  previous  studies  showed  no  statisti-
ally  signiﬁcant  differences  in  sociodemographic  conditions
r  perinatal  outcomes  between  the  two  groups.7,29 Besides
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140  
he  smaller  rate  of  pregestational  DM  (0.2  to  0.3%)  in  other
tudies,1 it  is  likely  that  the  present  observations  represent
he  general  trends  in  outcome  of  these  infants.
The  present  data  suggest  that  with  modern  management
nd  adequate  prenatal  care  there  is  no  signiﬁcant  increase
n  mortality  rates  or  early  morbidity  rates  in  VLBWI  born  to
others  with  DM,  except  NEC.  It  appears  that,  with  reason-
ble  diabetic  control,  prematurity  rather  than  the  diabetic
tate  determines  the  neonatal  outcome.
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